carbostyril has been researched along with Soft Tissue Infections in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adam, HJ; Baxter, M; Karlowsky, JA; Lagace-Wiens, PRS; Zhanel, GG | 1 |
| Biedenbach, DJ; Jones, RN; Kirby, JT; Mutnick, AH; Pfaller, MA | 1 |
| Schweiger, ES; Weinberg, JM | 1 |
| Citron, DM; Goldstein, EJ; Hudspeth, M; Hunt Gerardo, S; Merriam, CV | 1 |
| Citron, DM; Fernandez, H; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA | 1 |
1 review(s) available for carbostyril and Soft Tissue Infections
| Article | Year |
|---|---|
Novel antibacterial agents for skin and skin structure infections.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Humans; Linezolid; Oxazolidinones; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections; Virginiamycin | 2004 |
4 other study(ies) available for carbostyril and Soft Tissue Infections
| Article | Year |
|---|---|
In vitro activity and resistance rates of topical antimicrobials fusidic acid, mupirocin and ozenoxacin against skin and soft tissue infection pathogens obtained across Canada (CANWARD 2007-18).
Topics: Aminopyridines; Anti-Bacterial Agents; Canada; Fusidic Acid; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Quinolones; Soft Tissue Infections; Staphylococcal Infections; Staphylococcus aureus | 2021 |
Geographic variations in garenoxacin (BMS284756) activity tested against pathogens associated with skin and soft tissue infections: report from the SENTRY Antimicrobial Surveillance Program (2000).
Topics: Anti-Infective Agents; Bacteria; Drug Resistance, Bacterial; Europe; Fluoroquinolones; Humans; Indoles; Latin America; Microbial Sensitivity Tests; North America; Population Surveillance; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections | 2002 |
In vitro activity of Bay 12-8039, a new 8-methoxyquinolone, compared to the activities of 11 other oral antimicrobial agents against 390 aerobic and anaerobic bacteria isolated from human and animal bite wound skin and soft tissue infections in humans.
Topics: Administration, Oral; Anti-Infective Agents; Aza Compounds; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Bites, Human; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Skin Diseases, Bacterial; Soft Tissue Infections; Wound Infection | 1997 |
In vitro activities of the des-fluoro(6) Quinolone BMS-284756 against aerobic and anaerobic pathogens isolated from skin and soft tissue animal and human bite wound infections.
Topics: Animals; Anti-Infective Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bites and Stings; Cats; Dogs; Fluoroquinolones; Humans; Indoles; Microbial Sensitivity Tests; Quinolones; Skin Diseases, Infectious; Soft Tissue Infections | 2002 |